Table 1

Characteristics of study population
Healthy sample Overall sample
male female male female
N 342 859 1275 1577
Age , years 46.2 ± 15.4 46.7 ± 13.8 52.5 ± 12.7 54.0 ± 14.9
BaPWV, cm/s 1339.3 ± 224.8 1294.8 ± 241.9 1524.8 ± 355.7 1578.6 ± 463.6
BMI, kg/m2 23.8 ± 2.9 22.8 ± 2.9 24.7 ± 3.2 23.9 ± 3.4
MAP, mmHg 89.8 ± 7.3 85.3 ± 8.8 97.9 ± 18.8 94.7 ± 13.3
SBP, mmHg 123.9 ± 13.2 120.6 ± 12.1 131.8 ± 17.9 130.9 ± 20.9
DBP, mmHg 74.4 ± 7.5 70.2 ± 8.4 80.9 ± 24.1 76.6 ± 10.9
Pulse pressure, mmHg 46.0 ± 7.9 45.3 ± 9.1 50.9 ± 24.9 54.5 ± 14.9
HR, beats/min 70.8 ± 9.4 71.4 ± 9.4 70.9 ± 10.2 71.6 ± 10.1
TC, mmol/L 4.57 ± 0.81 4.75 ± 0.94 4.73 ± 0.94 5.09 ± 1.06
HDL-C, mmol/L 1.37 ± 0.29 1.44 ± 0.33 1.29 ± 0.29 1.39 ± 0.33
LDL-C, mmol/L 2.67 ± 0.62 2.75 ± 0.83 2.81 ± 0.76 3.02 ± 0.91
TG, mmol/L 1.53 ± 1.04 1.31 ± 0.87 1.80 ± 1.27 1.59 ± 0.99
Fasting glucose, mmol/L 4.9 ± 0.6 4.9 ± 0.5 5.4 ± 1.4 5.4 ± 1.6
Hypertension, % 0 0 50.3 47.8
Diabetes, % 0 0 23.7 21.1
Smoking, % 0 0 50.2 3.7
Stroke, % 0 0 7.2% 6.5%
Ischemic heart disease, % 0 0 10.9 7.1
Medication
ACEIs/ARBs, % 0 0 9.9 8.9
Statins, % 0 0 6.6 4.9
CCBs, % 0 0 15.3 14.5

BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, MAP Mean arterial pressure; BaPWV Brachial-ankle pulse wave velocity, CCBs Calcium channel blockers, ACEIs angiotensin converting enzyme inhibitors, ARBs angiotensin receptor blockers, HR heart rate, TC total cholesterol, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, TG triglyceride.

Wang et al.

Wang et al. BMC Cardiovascular Disorders 2012 12:119   doi:10.1186/1471-2261-12-119

Open Data